265 related articles for article (PubMed ID: 18717856)
1. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
Ozdöl S; Sahin S; Tokgözoğlu L
Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
[TBL] [Abstract][Full Text] [Related]
2. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma).
Pandhi D; Gupta P; Singal A; Tondon A; Sharma S; Madhu SV
Postgrad Med J; 2012 Apr; 88(1038):198-204. PubMed ID: 22362903
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis and clinical significance of xanthelasma palpebrarum.
Bergman R
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
[TBL] [Abstract][Full Text] [Related]
4. Xanthelasma is not associated with increased risk of carotid atherosclerosis in normolipidaemia.
Chan CC; Lin SJ; Hwang JJ; Sun CC; Jeng JS; Hwang BS; Chiu HC; Chen MF; Liau CS; Hsu HJ; Su TC
Int J Clin Pract; 2008 Feb; 62(2):221-7. PubMed ID: 18036167
[TBL] [Abstract][Full Text] [Related]
5. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.
Segal P; Insull W; Chambless LE; Stinnett S; LaRosa JC; Weissfeld L; Halfon S; Kwiterovitch PO; Little JA
Circulation; 1986 Jan; 73(1 Pt 2):I108-18. PubMed ID: 3940677
[TBL] [Abstract][Full Text] [Related]
6. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
8. Xanthelasma palpebrum--a marker for hyperlipidemia in NIDDM patients?
Premalatha G; Mohan V
J Assoc Physicians India; 1996 Jan; 44(1):73-4. PubMed ID: 8773112
[No Abstract] [Full Text] [Related]
9. Xanthelasma palpebrarum.
Cohen PR
J Gt Houst Dent Soc; 1996; 67(9):10-1. PubMed ID: 9594794
[No Abstract] [Full Text] [Related]
10. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management of hyperlipidemia-induced atherosclerosis.
Tannock LR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
[TBL] [Abstract][Full Text] [Related]
13. [KTP laser coagulation for xanthelasma palpebrarum].
Berger C; Kopera D
J Dtsch Dermatol Ges; 2005 Oct; 3(10):775-9. PubMed ID: 16194155
[TBL] [Abstract][Full Text] [Related]
14. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
15. An Updated Work-Up for Patients With Xanthelasma Palpebrarum.
Rothstein BE; Cohen JL
Dermatol Surg; 2021 Aug; 47(8):1170-1171. PubMed ID: 33988552
[No Abstract] [Full Text] [Related]
16. Relationship Between Xanthelasma Palpebrarum and Hyperlipidemia.
Wang KY; Hsu KC; Liu WC; Yang KC; Chen LW
Ann Plast Surg; 2018 Feb; 80(2S Suppl 1):S84-S86. PubMed ID: 29424765
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
18. Hyperlipidemia in patients with periodontitis.
Moeintaghavi A; Haerian-Ardakani A; Talebi-Ardakani M; Tabatabaie I
J Contemp Dent Pract; 2005 Aug; 6(3):78-85. PubMed ID: 16127475
[TBL] [Abstract][Full Text] [Related]
19. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.
Souki-Rincón A; Urdaneta J; Mengual E; Torres D; Cano-Peñaloza R; García-Camacho D; Bermúdez-Pírela V; Sorell L; Cano-Ponce C; Almarza J; Israili Z; Hernández-Hernandez R; Velasco M
Am J Ther; 2008; 15(4):403-8. PubMed ID: 18645346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
